Trial Information

Before transplantation 300 patients will be randomized 1:1:1 in three groups. Group 1 will
be treated with basiliximab induction and a three day course of steroids followed by a
steroid free maintenance regimen consisting of standard-dose tacrolimus OD and mycophenolic
acid. Group 2 will be treated with Basiliximab induction followed by standard-dose
tacrolimus OD, mycophenolic acid and steroids. Group 3 will be treated with basiliximab
induction followed by standard-dose tacrolimus OD for six months, whereafter the dose will
be reduced plus mycophenolic acid and steroids. The total study period will be 2 years.
Primary endpoint will be renal function, proteinuria and microalbuminuria measured 6, 12,
and 24 months after transplantation. Renal function will be measured by serum Creatinine,
Creatinine clearances and Nankivell GFR (4). Secondary endpoints will be the degree of
tubular atrophy and interstitial fibrosis and the degree of arteriolar hyalinosis in renal
biopsies taken at 12 and 24 months after transplantation. Biopsies will be evaluated
according to the Banff '07 Criteria for Renal Allograft Biopsy Interpretation (appendix II).
Quantitative morphometric analysis of interstitial fibrous tissue will be performed using
the digital image analysis technique. Other secondary endpoints are patient and graft
survival, the incidence of allograft rejection, cardiovascular accidents, pulse wave
velocity, blood pressure, the number of antihypertensives, lipid profile, the incidence of
malignancies, the incidence of infectious complications, the incidence of post transplant
diabetes mellitus and the development of osteoporosis.

Inclusion Criteria:

- recipient of a kidney graft (first of second) from a deceased or living (non-HLA
identical) donor

Completion Date:

Related Keywords:

Name

Location

We are a Cancer Social Network, Resource Directory & Education Hub supporting all those affected by cancer. knowcancer.com is intended to be solely for informational purposes and should not be a substitute for professional medical advice, diagnosis or treatment.